Panel of X-linked single-nucleotide polymorphic markers for DNA identification (XSNPid) based on multiplex genotyping by multilocus PCR and MALDI-TOF mass spectrometry
- Authors: Stepanov V.A.1,2, Vagaitseva K.V.1,2, Kharkov V.N.1,2, Cherednichenko A.A.1, Bocharova A.V.1
-
Affiliations:
- Research Institute for Medical Genetics
- National Research Tomsk State University
- Issue: Vol 50, No 3 (2016)
- Pages: 387-397
- Section: Genomics. Transcriptomics
- URL: https://journal-vniispk.ru/0026-8933/article/view/162662
- DOI: https://doi.org/10.1134/S0026893316030158
- ID: 162662
Cite item
Abstract
Human genetic markers linked with the X chromosome (X-linked) are used in the field of population and medical genetics, as well as for DNA identification of individuals in forensic science and forensic medicine. We proposed an XSNPid panel that consists of 66 unlinked single nucleotide X chromosome markers and developed a protocol for their multiplex genotyping using multilocus PCR and MALDI-TOF mass spectrometry. The XSNPid panel is genotyped within two multiplexes (36 and 30 markers). The developed protocol provides an efficient genotype reading; the fraction of determined genotypes is 98.29%. The high level of gene diversity (0.461) for the X-linked SNPs included in the panel is characteristic of the Russian population. A total of 63 out of 66 markers that provide a high efficiency of genotyping and independent inheritance are suitable for DNA identification purposes. The XSNPid panel is characterized by a very high discriminating ability when studying the Russian population. The probability of genotype coincidence in two unrelated individuals is 9 × 10–27 for women and 2 × 10–18 for men. Also, the XSNPid panel has a greater multiplex capacity in addition to a higher discriminating ability compared to the other closest analogues of the X chromosome SNP sets, which makes it more cost effective and less time consuming. The XSNPid panel is a convenient tool, not only for individual DNA identification, but also for population genetic studies.
About the authors
V. A. Stepanov
Research Institute for Medical Genetics; National Research Tomsk State University
Author for correspondence.
Email: vadim.stepanov@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050
K. V. Vagaitseva
Research Institute for Medical Genetics; National Research Tomsk State University
Email: vadim.stepanov@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050
V. N. Kharkov
Research Institute for Medical Genetics; National Research Tomsk State University
Email: vadim.stepanov@medgenetics.ru
Russian Federation, Tomsk, 634050; Tomsk, 634050
A. A. Cherednichenko
Research Institute for Medical Genetics
Email: vadim.stepanov@medgenetics.ru
Russian Federation, Tomsk, 634050
A. V. Bocharova
Research Institute for Medical Genetics
Email: vadim.stepanov@medgenetics.ru
Russian Federation, Tomsk, 634050
Supplementary files
